PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.\', \'Vaccine Research Institute, Creteil, France.\', \'Inserm U955, Créteil, France.\', \'Baylor Scott and White Research Institute and INSERM U955, Dallas, TX, USA.\', \'Service of Immunology and Allergy Lausanne University Hospital, Lausanne, Switzerland.\', \'Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.\', \'Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.\', \'Virus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France.\', \'CNRS UMR 3569, Paris, France.\', \'Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur, CNRS UMR 3569, Université de Paris, Paris, France.\', \'National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.\', \'Univ. Bordeaux, Department of Public Health, Inserm Bordeaux Population Health Research Centre, Inria SISTM, Bordeaux, France.\', \'CHU Bordeaux, Department of Medical information, Bordeaux, France.\', \'Vaccine Research Institute, Creteil, France. yves.levy@inserm.fr.\', \'Inserm U955, Créteil, France. yves.levy@inserm.fr.\', \'AP-HP, Hôpital Henri-Mondor Albert-Chenevier, Service d\'Immunologie Clinique et Maladies Infectieuses, Créteil, France. yves.levy@inserm.fr.\', \'Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France. roger.le-grand@cea.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-25382-0
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34471122
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34471122>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34471122>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all